| Personalised 3D printed medicines: which techniques and polymers are more successful? AA Konta, M García-Piña, DR Serrano Bioengineering 4 (4), 79, 2017 | 353 | 2017 |
| Technology‐enhanced learning in higher education: How to enhance student engagement through blended learning DR Serrano, MA Dea‐Ayuela, E Gonzalez‐Burgos, A Serrano‐Gil, ... European Journal of Education 54 (2), 273-286, 2019 | 321 | 2019 |
| Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale R Fernández-García, A Lalatsa, L Statts, F Bolás-Fernández, ... International journal of pharmaceutics 573, 118817, 2020 | 214 | 2020 |
| Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles DR Serrano, A Lalatsa, MA Dea-Ayuela, PE Bilbao-Ramos, NL Garrett, ... Molecular pharmaceutics 12 (2), 420-431, 2015 | 125 | 2015 |
| Drug delivery nanosystems for the localized treatment of glioblastoma multiforme L Nam, C Coll, LCS Erthal, C De la Torre, D Serrano, R Martínez-Máñez, ... Materials 11 (5), 779, 2018 | 104 | 2018 |
| Drug stability: ICH versus accelerated predictive stability studies O González-González, IO Ramirez, BI Ramirez, P O’Connell, ... Pharmaceutics 14 (11), 2324, 2022 | 93 | 2022 |
| 3D printing technologies in personalized medicine, nanomedicines, and biopharmaceuticals DR Serrano, A Kara, I Yuste, FC Luciano, B Ongoren, BJ Anaya, G Molina, ... Pharmaceutics 15 (2), 313, 2023 | 92 | 2023 |
| New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp HK Ruiz, DR Serrano, MA Dea-Ayuela, PE Bilbao-Ramos, ... International journal of pharmaceutics 473 (1-2), 148-157, 2014 | 92 | 2014 |
| Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations DR Serrano, L Hernandez, L Fleire, I González-Alvarez, A Montoya, ... International journal of pharmaceutics 447 (1-2), 38-46, 2013 | 83 | 2013 |
| 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms S Ayyoubi, JR Cerda, R Fernández-García, P Knief, A Lalatsa, AM Healy, ... International Journal of Pharmaceutics 597, 120336, 2021 | 80 | 2021 |
| Personalised 3D printed medicines: Optimising material properties for successful passive diffusion loading of filaments for fused deposition modelling of solid dosage forms JR Cerda, T Arifi, S Ayyoubi, P Knief, MP Ballesteros, W Keeble, E Barbu, ... Pharmaceutics 12 (4), 345, 2020 | 80 | 2020 |
| Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties C Grossjohann, DR Serrano, KJ Paluch, P O’Connell, L Vella-Zarb, ... Journal of pharmaceutical sciences 104 (4), 1385-1398, 2015 | 76 | 2015 |
| Cocrystal habit engineering to improve drug dissolution and alter derived powder properties DR Serrano, P O'Connell, KJ Paluch, D Walsh, AM Healy Journal of Pharmacy and Pharmacology 68 (5), 665-677, 2016 | 72 | 2016 |
| Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting R Fernández-García, E de Pablo, MP Ballesteros, DR Serrano International journal of pharmaceutics 525 (1), 139-148, 2017 | 70 | 2017 |
| Oral fixed-dose combination pharmaceutical products: Industrial manufacturing versus personalized 3D printing R Fernández-García, M Prada, F Bolás-Fernández, MP Ballesteros, ... Pharmaceutical research 37, 1-22, 2020 | 65 | 2020 |
| Designing fast-dissolving orodispersible films of amphotericin B for oropharyngeal candidiasis DR Serrano, R Fernandez-Garcia, M Mele, AM Healy, A Lalatsa Pharmaceutics 11 (8), 369, 2019 | 57 | 2019 |
| Engineering of pharmaceutical cocrystals in an excipient matrix: Spray drying versus hot melt extrusion D Walsh, DR Serrano, ZA Worku, AM Madi, P O'Connell, B Twamley, ... International Journal of Pharmaceutics 551 (1-2), 241-256, 2018 | 57 | 2018 |
| Production of cocrystals in an excipient matrix by spray drying D Walsh, DR Serrano, ZA Worku, BA Norris, AM Healy International Journal of Pharmaceutics 536 (1), 467-477, 2018 | 56 | 2018 |
| Orally bioavailable and effective buparvaquone lipid-based nanomedicines for visceral leishmaniasis L Smith, DR Serrano, M Mauger, F Bolás-Fernández, MA Dea-Ayuela, ... Molecular pharmaceutics 15 (7), 2570-2583, 2018 | 54 | 2018 |
| Mimicking bone microenvironment: 2D and 3D in vitro models of human osteoblasts I Yuste, FC Luciano, E González-Burgos, A Lalatsa, DR Serrano Pharmacological Research 169, 105626, 2021 | 53 | 2021 |
Aikaterini LalatsaReader in Nanomedicines, University of StrathclydeПотвърден имейл адрес: strath.ac.uk